Tushar Adhikari | Phytochemistry | Research Excellence Award

Published on by sciencefatherLeave a Comment on Tushar Adhikari | Phytochemistry | Research Excellence Award

Mr. Tushar Adhikari | Phytochemistry | Research Excellence Award

Guru Nanak Institute of Pharmaceutical Science and Technology | India

Mr. Tushar Adhikari is an emerging academic and researcher in the field of pharmaceutical sciences, with a strong foundation in pharmaceutical chemistry and phytochemistry. He completed his M.Pharm. with a specialization in Pharmaceutical Chemistry from Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, securing First Class Honours, following his B.Pharm. from Adamas University with First Class Honours. His academic journey reflects consistent excellence from secondary education through postgraduate studies. Since August 2022, he has been serving as an Assistant Professor at Guru Nanak Institute of Pharmaceutical Science and Technology, where he has accumulated over 1.5 years of teaching, research, and administrative experience. His research interests are primarily centered on phytochemistry, with hands-on expertise in extraction, fractionation, isolation, purification, and characterization of bioactive phytoconstituents, particularly flavonoids, using advanced chromatographic and spectroscopic techniques such as HPTLC, TLC, column chromatography, UV, IR, and AAS. In addition, he has exposure to computer-aided drug design, including molecular docking, 2D and 3D QSAR, and pharmacophore modeling. His academic distinctions, teaching contributions, and interdisciplinary research orientation highlight his commitment to advancing pharmaceutical education and research, positioning him as a promising contributor to future innovations in drug discovery and natural product research.

Featured Publications


Phytochemistry and Pharmacological Potential of Alocasia macrorrhiza: A Comprehensive Review

– Journal of Applied Pharmaceutical Research, 2024, Vol. 12 (Issue 6)

Pengyuan Wang | Pancreatitis | Young Researcher Award

Published on by sciencefatherLeave a Comment on Pengyuan Wang | Pancreatitis | Young Researcher Award

Mr. Pengyuan Wang | Pancreatitis | Young Researcher Award

Department of Gastroenterology, Changhai Hospital, Naval Medical University | China

Mr. Pengyuan Wang is an accomplished biomedical researcher and clinician specializing in gastroenterology and translational pharmacology. He obtained a Bachelor’s degree in Clinical Medicine, followed by a Ph.D. in Pharmacology, and further strengthened his academic foundation through postdoctoral training in Gastroenterology. He is currently affiliated with leading clinical and research centers in China, where he integrates clinical insight with mechanistic research to address complex gastrointestinal diseases. His professional experience bridges patient-oriented practice and laboratory-based investigation, enabling a strong bench-to-bedside research approach. Mr. Wang’s primary research interest focuses on the metabolic mechanisms underlying pancreatitis, with particular emphasis on identifying key molecular pathways involved in disease initiation and progression. In parallel, he is actively engaged in drug screening and pharmacological evaluation, aiming to discover and optimize therapeutic candidates for pancreatitis and related metabolic disorders. His work contributes to improving diagnostic strategies and advancing targeted treatments in gastroenterology. Recognized for his rigorous scientific approach and interdisciplinary expertise, he has received academic acknowledgment through competitive research training and scholarly contributions. Overall, Mr. Wang’s research continues to enhance the understanding of pancreatitis pathophysiology and supports the development of innovative therapeutic interventions with significant clinical relevance.

View ORCID Profile

Featured Publications

Assist. Prof. Dr. Xiancai Li | Natural Products Chemistry | Research Excellence Award

Published on by sciencefather

Assist. Prof. Dr. Xiancai Li | Natural Products Chemistry | Research Excellence Award

South China Botanical Garden, Chinese Academy of Sciences, China

Assist Prof. Dr. Xiancai Li is a dedicated pharmacological researcher recognized for his strong contributions to plant-based therapeutic discovery, particularly in the antimicrobial and uric-acid-lowering potential of natural products. With extensive experience in molecular biology and phytochemical research, he has developed deep expertise in transcriptomic and metabolomic analysis, enabling him to elucidate complex biochemical pathways and identify novel bioactive compounds. He earned his Bachelor of Science in plant protection, followed by a Ph.D. in science, where he focused on natural product pharmacology and plant-derived mechanisms of disease mitigation. His postdoctoral research at the Institute of Genetics and Developmental Biology further strengthened his proficiency in functional genomics and biological validation techniques, leading to several impactful publications in reputable scientific journals. Currently serving as a Research Associate at the South China Botanical Garden, Chinese Academy of Sciences, he continues to advance innovative pharmacological studies with an emphasis on plant resources for drug discovery. His research interests span antimicrobial resistance, metabolic regulation, phytotherapy, and natural product innovation. Throughout his career, he has been recognized with academic honors and research achievements that highlight his commitment to scientific excellence. Dr. Li remains dedicated to advancing evidence-based natural medicine and contributing to global health solutions.

Profile: Orcid

Featured Publications

Li, X., Yu, W., Yao, L., Liu, F., Li, Y., Xiong, B., Xie, J., & Qiu, S.-X. (2026). “Amelioration effects of Cajanus cajan extracts and the active ingredient pinostrobin on hyperuricemia and related kidney injury.” Food & Function.
https://doi.org/10.1039/D5FO01806D

Li, X., Chen, S., Wu, Y., Liu, F., Jumai, A., Zhu, B., Xiong, B., & Qiu, S.-X. (2026). “γ-mangostin from Garcinia mangostana (L.) exerts antifungal activity against Cryptococcus neoformans by inhibiting ribosome biogenesis.” Journal of Ethnopharmacology, March 2026. https://doi.org/10.1016/j.jep.2025.120986

Camilla Djenne Buarque Muller | Medicinal Chemistry | Best Researcher Award

Published on by sciencefather

Prof. Dr. Camilla Djenne Buarque Muller | Medicinal Chemistry | Best Researcher Award

PUC-Rio | Brazil

Prof. Dr. Camilla Djenne Buarque Müller is a distinguished Brazilian chemist recognized for her impactful contributions to synthetic organic chemistry, natural products chemistry, and medicinal chemistry. She earned her Ph.D. and M.Sc. in Chemistry from the Federal University of Rio de Janeiro (UFRJ), where she conducted innovative research on pterocarpans, aza-pterocarpans, and palladium-catalyzed arylation strategies. Her academic career includes key faculty positions at the Pontifical Catholic University of Rio de Janeiro (PUC-Rio), where she progressed from Assistant Professor to Associate Professor, and currently continues her scientific leadership at Fluminense Federal University (UFF). Prof. Müller has also held important roles within the Brazilian Chemical Society (SBQ), serving as Vice-Secretary and Secretary of SBQ-Rio. Her research interests span heterocyclic synthesis, triazole hybrids, CFTR modulator development, covalent organic frameworks, and structure-activity relationships applied to drug discovery. She has received numerous prestigious honors, including Research Productivity Fellowships (CNPq), Scientist of Our State (FAPERJ), Young Scientist of Our State, Best Poster Awards, and multiple recognitions for excellence in undergraduate and graduate supervision. Prof. Müller continues to advance chemistry through impactful publications, mentorship, and contributions that strengthen Brazil’s scientific community.

Profiles: Scopus | Orcid

Featured Publications

Zeitune, D. C., Azevedo, M. F. M. F., Rangel, M. S., Bastos, R. de S., Neto, J. de B. V., Pessoa, C. do Ó., & Buarque, C. D. (2025). Synthesis and antitumoral activity of novel biaryl hydroxy-triazole and fluorene-triazole hybrids. Exploration of Drug Science.

Carneiro, L. S. A., & Buarque, C. D. (2025). Arylation of C=C bonds via non-cross-coupling reactions: historical evolution of the Meerwein arylation mechanisms. ChemTexts.

Azevedo, M. F. M. F., Zeitune, D. C., de Farias, R. L., Junior, E. N. C., Bacalhau, M., Amaral, M. D., Lopes-Pacheco, M., & Buarque, C. D. (2025). Direct access of 4-acyl-1,2,3-triazoles from acetophenones: A synthetic shortcut for novel p.Phe508del-CFTR traffic correctors. Journal of Molecular Structure.

Bacalhau, M., Ferreira, F. C., Azevedo, M. F. M. F., Rosa, T. P., Buarque, C. D., & Lopes-Pacheco, M. (2025). Rescue of mutant CFTR channel activity by investigational co-potentiator therapy. Biomedicines.

Cifuentes, J. M. C., Henrique, F. J. F. S., Ligiéro, C. B. P., Esteves, P. M., & Buarque, C. D. (2024). Covalent organic frameworks as a versatile platform for iron-catalyzed sp³ C–H activation and cross-coupling via decarboxylative oxidation. European Journal of Inorganic Chemistry.

Ferreira, F., Buarque, C., & Lopes-Pacheco, M. (2024). Organic synthesis and current understanding of the mechanisms of CFTR modulator drugs Ivacaftor, Tezacaftor, and Elexacaftor. Molecules.

da Silva, V. D., Zalewska, K., Petrovski, Z., Buarque, C. D., Branco, L. C., & Esteves, P. M. (2023). Covalent organic frameworks as promising materials for the removal of metal and organic pollutants from water. Materials Today Sustainability.

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Published on by sciencefather

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Changzhou University | China

Dr. Hongyan Lin is a distinguished researcher and lecturer at the School of Pharmaceutical Sciences, Changzhou University, China, with a strong emphasis on natural product chemistry and molecular pharmacology. She completed her Bachelor’s degree in Bioengineering at Changzhou University, followed by an Integrated Master-PhD in Biology at Nanjing University, where she specialized in the biological mechanisms of traditional medicine. Dr. Lin further expanded her expertise as a Postdoctoral Fellow and Research Associate at the School of Life Sciences, Nanjing University, contributing significantly to molecular pharmacology and natural product research. Her research interests focus on the chemical structural modification of natural products for anticancer applications, the role of traditional Chinese medicine in regulating intestinal microbiota to prevent colitis-associated cancer, and the isolation, structural identification, and biological activity of bioactive compounds from traditional herbs. Dr. Lin has been recognized for her scientific contributions through research grants and academic publications in high-impact journals. Her work supports the evolution of natural product-based therapeutics and offers promising directions for cancer prevention and treatment. In her role as a lecturer and researcher, she continues to inspire the next generation of pharmaceutical scientists through her dedication and innovation.

Profiles: Scopus | Orcid

Featured Publications

Lin, H., Ai, D., Liu, Q., Wang, X., Gao, J., Chen, Q., Ruan, L., Tao, Y., Gao, J., & Wang, L. (2023). Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products, Published online July 28, 2023.

Lin, H., Zhou, Z., Ma, X., Chen, Q., Han, H., Wang, X., Qi, J., & Yang, Y. (2021). One pot synthesis of aryl nitriles from aromatic aldehydes in a water environment. RSC Advances, 2021.

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Published on by sciencefather

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Wuhan University - China

Author Profile

Early Academic Pursuits

Ms. Yufang Ma's academic journey began with a fervent interest in the biomedical sciences. She completed her undergraduate studies with a focus on pharmacology, where she developed a strong foundation in understanding drug interactions and biological systems. Her early research interests centered around natural compounds, particularly flavonoids, which are known for their diverse pharmacological properties. This interest led her to delve deeper into the conformational relationships of these compounds, exploring how their structures influence their biological activities. Her dedication to her studies was reflected in her academic excellence and active participation in various research initiatives.

Professional Endeavors

Following her undergraduate studies, Ms. Yufang Ma pursued a Master's degree at Wuhan University, one of the top institutions in China. Her professional endeavors have been marked by her commitment to advancing pharmacological research. At Wuhan University, she has been primarily engaged in studying the conformational relationships of flavonoids and their pharmacological effects. Her research aims to uncover the therapeutic potential of these natural compounds, particularly in the context of treating neurological disorders such as epilepsy. This work not only contributes to the scientific community's understanding of flavonoids but also has the potential to lead to the development of new, effective treatments for epilepsy.

Contributions and Research Focus

Ms. Yufang Ma's contributions to pharmacological research are centered on her in-depth studies of flavonoids. Her primary research focus involves investigating the conformational relationships of these compounds and how their structural variations impact their pharmacological properties. She is particularly interested in the therapeutic potential of flavonoids in treating epilepsy, a neurological disorder characterized by recurrent seizures. Through her research, she aims to identify specific flavonoids that can modulate neuronal activity and reduce seizure frequency. This focus on epilepsy research is a significant contribution to the field, as it addresses a critical need for new, effective treatments for this debilitating condition.

Accolades and Recognition

While Yufang Ma's work is ongoing, she has already garnered recognition for her contributions to pharmacological research. Her dedication to exploring the therapeutic potential of flavonoids has been acknowledged by her peers and mentors at Wuhan University. Although she has not yet published extensively or secured patents, her research on epilepsy is paving the way for significant advancements in the field. The recognition she has received serves as a testament to her potential to make impactful contributions to pharmacology and therapeutics.

Impact and Influence

The impact of Yufang Ma's research extends beyond the academic community. Her work on flavonoids and epilepsy has the potential to influence the development of new pharmacological treatments. By identifying specific flavonoids with anticonvulsant properties, her research could lead to the creation of novel therapies that offer better efficacy and fewer side effects compared to existing treatments. This potential impact highlights the broader significance of her work in improving patient outcomes and enhancing the quality of life for individuals with epilepsy.

Legacy and Future Contributions

Ms. Yufang Ma's legacy in pharmacological research is still in the making, but her ongoing work promises to leave a lasting impact on the field. As she continues to explore the therapeutic potential of flavonoids, her findings could pave the way for new treatment paradigms in epilepsy and other neurological disorders. Her future contributions are likely to extend beyond research, potentially influencing clinical practices and drug development strategies. With her dedication and innovative approach, Ms. Yufang Ma is poised to become a leading figure in pharmacology, contributing to the advancement of science and the improvement of human health.

Notable Publication

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity, 2024.

Diosmetin Ameliorates HFD-induced Cognitive Impairments via Inhibiting Metabolic Disorders, Mitochondrial Dysfunction and Neuroinflammation in Male SD Rats, 2024